[1] Siegel R,Naishadham D,Jemal A.Cancer statistics[J].CA Cancer J Clin,2012,62(1):10-29.[2] Ellis LM.The role of neuropilins in cancer[J].Mol Cancer Ther,2006,5(5):1099-1107.[3] Cheng W,Fu D,Wei ZF,et al.NRP-1 expression in bladder cancer and its implications for tumor progression[J].Tumour Biol,2014,35(6):6089-6094.[4] Glinka Y,Mohammed N,Subramaniam V,et al.Neuropilin-1 is expressed by breast cancer stem-like cells and is linked to NF-kappaB activation and tumor sphere formation[J].Biochem Biophys Res Commun,2012,425(4):775-780.[5] Nass D,Rosenwald H,Meiri E,et al.MiR-92b and miR-9/9* are specifically expressed in brain primary tumors and can be used to differentiate primary from metastatic brain tumors[J].Brain Pathol,2009,19(3):375-383.[6] Selcuklu SD,Donoghue MT,Rehmet K,et al.MicroRNA-9 inhibition of cell proliferation and identification of novel miR-9 targets by transcriptome profiling in breast cancer cells[J].J Biol Chem,2012,287(35):29516-29528.[7] Wu S,Jia S,Xu P.MicroRNA-9 as a novel prognostic biomarker in human laryngeal squamous cell carcinoma[J].Int J Clin Exp Med,2014,7(12):5523-5528.[8] Osada H,Tokunaga T,Nishi M,et al.Overexpression of the neuropilin 1(NRP1) gene correlated with poor prognosis in human glioma[J].Anticancer Res,2004,24(2B):547-552.[9] Li Q,Li Q,Nuccio J,et al.Metastasis initiating cells in primary prostate cancer tissues from transurethral resection of the prostate (TURP) predicts castration-resistant progression and survival of prostate cancer patients[J].Prostate,2015,75(12):1312-1321.[10] 谭双.非小细胞肺癌中NRP1和C-MET的表达与血管生成的关系[J].中国老年学杂志,2013,33(8):1767-1769.[11] Ambros V.microRNAs:tiny regulators with great potential[J].Cell,2001,107(7):823-826.[12] 张海芹,董娟聪,金霖霖,等.miR-9对NRP1的靶向调控及其在辐射效应中的作用研究[J].中华放射医学与防护杂志,2014,34(10):725-728.[13] Wu Z,Wang L,Li G,et al.Increased expression of microRNA-9 predicts an unfavorable prognosis in human glioma[J].Mol Cell Biochem,2013,384(1/2):263-268.[14] Li X,Pan Q,Wan X,et al.Methylation-associated Has-miR-9 deregulation in paclitaxel-resistant epithelial ovarian carcinoma[J].BMC Cancer,2015,15:509-518.[15] Cai L,Cai X.Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma[J].Diagn Pathol,2014,9:1000-1005.[16] Xu T,Liu X,Han L,et al.Up-regulation of miR-9 expression as a poor prognostic biomarker in patients with non-small cell lung cancer[J].Clin Transl Oncol,2014,16(5):469-475. |